# A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants

> **NCT02111083** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 38 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Insulin Lispro

## Key facts

- **NCT ID:** NCT02111083
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111083, "A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02111083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*